The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Relive this lively discussion about the mind-body connection with Associate Professor Asya Rolls M.Sc.’02. An expert in sleep deprivation and brain research, Prof. Rolls explains how positive thinking can boost healing and immunity, impacting even the body’s ability to fight off cancer cells. Learn more about Prof. Rolls’ fascinating research by clicking the video above. […]
While the efficacy of the COVID-19 vaccinations has been well studied, little is known about whether those who have gotten one or both of the shots can still spread the virus. Now, a study hailed as a “game-changer” has demonstrated for the first time that people who catch the virus after being vaccinated are far less infectious — even after just the first dose. A joint team of researchers from the Technion and Israel’s Maccabi Healthcare Services found that the vaccine reduced the viral load significantly in COVID-positive people who have been inoculated versus those who haven’t received the vaccine….
Relive this inspiring discussion with three Berger Visiting Fellows who are stellar female students poised to become the influential scientists and entrepreneurs of tomorrow. One has already made advances combating antimicrobial resistance and is now researching treatments for Alzheimer’s. Another has worked in the aerospace industry, and her research involves building a rocket. You’ll get […]
Everyone knows taking a walk is good for your health and well-being. But to attain an even greater positive impact, people should actively interact with their surroundings, according to a recent Technion study. Smell the flowers. Feel the grass between your toes. Taste the honeysuckle. And yes, take a selfie in the botanical gardens. The findings, published recently in Conservation Biology, are particularly relevant during the pandemic as people spend more time in nature to lift their spirits. A team of Technion researchers conducted a study of 1,023 visitors to Israel’s lush Ramat Hanadiv Memorial Gardens and Nature Park to…
Nanosynex, an innovative medtech startup that traces its beginnings to Technion Professor Shulamit Levenberg’s lab, is now on the frontlines in Israel tackling the COVID-19 pandemic. The three year old-company, co-founded by alumnae Michelle Heymann MBA ’16 and Diane Abensur Bessin MBA ’16, is partnering with Israeli emergency medical services organization United Hatzalah to roll out COVID-19 rapid diagnostic kits. The launch is part of a pilot initiative to ramp up mass testing efforts. Even though Israel is the most vaccinated country on Earth, having doled out coronavirus vaccines to more than half its population (as of early February), COVID-19…
The prolific scientific response to the COVID-19 pandemic was nothing short of extraordinary, bringing hope and inspiration to humanity. At the Technion, researchers in more than 50 laboratories pivoted their work to focus on battling COVID-19 when outbreaks began appearing around the globe. As a result, they have produced innovative solutions to diagnose and contain […]
Industrial design, metallurgy and music — yes, music — all came together in this unique student project. Anastasia Kolomiets, a master’s student in the Technion Faculty of Architecture, designed and manufactured the first-ever titanium flute made with 3D-printing. This elegant recorder was honored with a photo in Wohlers Report, often referred to as the “bible” of 3D printing, and also placed third in the GE-Arcam UGM Competition 2019 for “Best Creative part.”
When treating cancer, researchers are always searching for ways to remove cancer cells while minimizing damage to the rest of the body. One possible approach is to find processes unique to cancer cells, and which would allow specific targeting. If such a process can be disrupted, only those cells would be affected. A process (or absence thereof) can be unique to some types of cancer, and not be present in others. In such a case, we would want a simple way to recognize whether a particular tumor possesses the unique trait or not. The implication of this question is whether…
Much about the inner workings of the brain remains a puzzle, even after years of progress in brain research. Now Technion researchers are putting together the pieces, with a focus on understanding the inner workings of the brain and treating neurodegenerative diseases. Hear Technion experts from the Allen and Jewel Prince Center for Neurodegenerative Disorders […]
Researchers from the Rappaport Faculty of Medicine at the Technion have uncovered a mechanism that translates the information stored in DNA into proteins. The study, published in Cell Reports, was led by molecular microbiology principal investigator Professor Mordechai Choder and Dr. Stephen Richard, with Dr. Tamar Ziv and Keren Bendalak of the Smoler Proteomics Center at the Technion.
Professor Meytal Landau of the Technion – Israel Institute of Technology, together with researchers at the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, and scientists in Israel and Spain, has discovered a remarkable antimicrobial peptide. The peptide is secreted on the skin of the Australian toadlet (Uperoleia mjobergii) as part of its immune system. The discovery could inspire the development of novel synthetic drugs to combat bacterial infections, and broadens our understanding of neurodegenerative diseases like Alzheimer’s. An antibacterial peptide that turns on and off The researchers solved the 3D molecular structure of the peptide, named uperin 3.5. They…
Starting this week, students, staff, and faculty at the Technion will receive a rapid COVID-19 test developed by one of its own: Professor Naama Geva-Zatorsky. The test is a welcome protective measure, coming at a moment when Israel has tightened its lockdown in an effort to curb the latest surge. Infection rates are at record highs despite a successful vaccination campaign, in which 70% of Israelis 60 years and over have already had their first COVID-19 shot. The test, called “NaorCov19,” rapidly diagnoses the SARS-CoV-2 virus from a saliva sample that is heated to 149 degrees Fahrenheit. If the sample…